19 Hepatitis C virus infection and alcohol

Biomedical Research Reports

Volumn 2, Issue C, 2000, Pages 363-388

  Everhart, James ^a,b   Herion, David ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957029633     PISSN: 18745326     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5326(00)80023-X     Document Type: Article

References (131)

1. De Bac C., Stroffolini T., Gaeta G.B., Taliani G., and Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 20 (1994) 1225-1230
2. Corrao G., Zambon A., Torchio P., Arico S., La Vecchia C., and di Orio F. Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol 28 (1998) 608-614
3. Bellentani S., Tiribelli C., Saccoccio G., et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 20 (1994) 1442-1449
4. Stroffolini T. Alcohol, HCV infection, and liver cirrhosis: is the cup half full or half empty?. J Hepatol 28 (1998) 728-730
5. Arico S., Corrao G., D'Amicis A., and Klatsky A.L. Alcoholic liver cirrhosis after the advent of hepatitis C virus: some reflections on its epidemiology and on the concept of attributable risk. Collaborative GESIA and AISF Groups. Gruppo Epidemiologico della Societa Italiana di Alcologia and Associazione Italiana per lo Studio del Fegato. Ital J Gastroenterol Hepatol 29 (1997) 75-80
6. Schiff E.R. Hepatitis C and alcohol. Hepatology 26 Suppl 1 (1997) 39S-42S
7. Grellier L.F., and Dusheiko G.M. The role of hepatitis C virus in alcoholic liver disease. Alcohol Alcohol 32 (1997) 103-111
8. Seeff L.B. Chronic hepatitis C: beware the older drinking male: fibrosis progression beckons!. Hepatology 26 4 (1997) 1074-1076
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Ameican Psychiatric Association, Washington, DC
10. Caetano R., Tam T., Greenfield T., Cherpitel C., and Midanik L. DSM-IV alcohol dependence and drinking in the U.S. population: a risk analysis. Ann Epidemiol 7 8 (1997) 542-549
11. Midanik L.T., and Clark W.B. Drinking-related problems in the United States: description and trends, 1984-1990. J Stud Alcohol 56 4 (1995) 395-402
12. Arico S., Galatola G., Tabone M., et al. The measure of life-time alcohol consumption in patients with cirrhosis: reproducibility and clinical relevance. Liver 15 4 (1995) 202-208
13. Morabia A., Moore M., and Wynder E.L. Reproducibility of food frequency measurements and inferences from a case-control study. Epidemiology 1 4 (1990) 305-310
14. Skinner H.A., and Sheu W.J. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 43 11 (1982) 1157-1170
15. Lemmens P.H. Measuring lifetime drinking histories. Alcohol: Clin Exp Res 22 2 Suppl (1998) 29S-36S
16. Poikolainen K. Underestimation of recalled alcohol intake in relation to actual consumption. Br J Addict 80 2 (1985) 215-216
17. Uchalik D.C. A comparison of questionnaire and self-monitored reports of alcohol intake in a nonalcoholic population. Addict Behav 4 4 (1979) 409-413
18. Verbaan H., Hoffmann G., Lindgren S., Nilsson S., Widell A., and Eriksson S. Long-term outcome of chronic hepatitis C infection in a low-prevalence area. Scand J Gastroenterol 33 6 (1998) 650-655
19. Corrao G., Bagnardi V., Zambon A., and Torchio P. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol 33 4 (1998) 381-392
20. Corrao G., Arico S., Zambon A., et al. Is alcohol a risk factor for liver cirrhosis in HBsAg and anti-HCV negative subjects? Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol 27 3 (1997) 470-476
21. Becker U., Deis A., Sorensen T.I., et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23 5 (1996) 1025-1029
22. Bellentani S., Saccoccio G., Costa G., et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41 6 (1997) 845-850
23. Prieto D.J., Carrion B.J., and Bandres M.F. Prevalence of hepatitis C virus and excessive consumption of alcohol in a nonhospital worker population. Gastroenterol Hepatol 20 10 (1997) 479-483
24. DHHS Publ. No. (PHS) 92-1387. Ezzati T.M., Massey J.T., Waksberg J., Chu A., and Maurer K.R. Sample design: Third National Health and Nutrition Examination Survey (1992), U.S. Department of Health and Human Services, Hyattsville, MD 1-113
25. Washington, DC. Anonymous. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94 1 32 (1994)
26. Befrits R., Hedman M., Blomquist L., et al. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterol 30 11 (1995) 1113-1118
27. Coelho-Little M.E., Jeffers L.J., Bernstein D.E., et al. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. Alcohol: Clin Exp Res 19 5 (1995) 1173-1176
28. Rosman A.S., Waraich A., Galvin K., Casiano J., Paronetto F., and Lieber C.S. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol 91 3 (1996) 498-505
29. Mendenhall C.L., Moritz T., Rouster S., et al. Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275. Am J Gastroenterol 88 7 (1993) 1022-1026
30. Verbaan H., Andersson K., and Eriksson S. Intravenous drug abuse-the major route of hepatitis C virus transmission among alcohol-dependent individuals?. Scand J Gastroenterol 28 8 (1993) 714-718
31. Strasser S.I. Hepatitis C: questions to be answered. Questions remain about virus transmission, the natural history of infection and the role of interferon in management. Med J Aust 164 3 (1996) 132-133
32. Fong T.L., Kanel G.C., Conrad A., Valinluck B., Charboneau F., and Adkins R.H. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 19 3 (1994) 554-557
33. Smith F.E., and Palmer D.L. Alcoholism, infection and altered host defenses: a review of clinical and experimental observations. J Chronic Dis 29 1 (1976) 35-49
34. Adams H.G., and Jordan C. Infections in the alcoholic. Med Clin North Am 68 1 (1984) 179-200
35. MacGregor R.R. Alcohol and immune defense. JAMA 256 11 (1986) 1474-1479
36. Cook R.T. Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol: Clin Exp Res 22 9 (1998) 1927-1942
37. MacGregor R.R., and Louria D.B. Alcohol and infection. Curr Clin Top Infect Dis 17 (1997) 291-315
38. Mendenhall C.L., Theus S.A., Roselle G.A., Grossman C.J., and Rouster S.D. Biphasic in vivo immune function after low- versus high-dose alcohol consumption. Alcohol 14 3 (1997) 255-260
39. Zignego A.L., Foschi M., Laffi G., et al. "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 19 3 (1994) 577-582
40. Nalpas B., Thiers V., Pol S., et al. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 14 2-3 (1992) 381-384
41. Sata M., Fukuizumi K., Uchimura Y., et al. Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases. J Viral Hepatitis 3 3 (1996) 143-148
42. Oshita M., Hayashi N., Kasahara A., et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 20 5 (1994) 1115-1120
43. Sawada M., Takada A., Takase S., and Takada N. Effects of alcohol on the replication of hepatitis C virus. Alcohol Alcohol Suppl 1B (1993) 85-90
44. Cromie S.L., Jenkins P.J., Bowden D.S., and Dudley F.J. Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol 25 6 (1996) 821-826
45. Pessione F., Degos F., Marcellin P., et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 27 6 (1998) 1717-1722
46. Mochida S., Ohnishi K., Matsuo S., Kakihara K., and Fujiwara K. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis. Alcohol: Clin Exp Res 20 9 Suppl (1996) 371A-377A
47. Sherman K.E., Mendenhall C., Thee D.L., O'Brien J., and Rouster S.D. Hepatitis C serotypes in nonalocholic and alcoholic patients. Dig Dis Sci 42 11 (1997) 2285-2291
48. Sherman K.E., Rouster S.D., Mendenhall C., and Thee D. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology 30 1 (1999) 265-270
49. Brillanti S., Masci C., Siringo S., Di Febo G., Miglioli M., and Barbara L. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 13 3 (1991) 347-350
50. Rothman K.J. Modern epidemiology (1986), Little, Brown, Boston, MA
51. Parés A., Barrera J.M., Caballeria J., et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 12 6 (1990) 1295-1299
52. Quintela A.G., Alende R., Aguilera A., et al. Hepatitis-C virus-antibodies in alcoholic patients. Revi Clin Espan 195 6 (1995) 367-372
53. (4 pt 1). Mendenhall C.L., Seeff L., Diehl A.M., et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119). Hepatology 14 (1991) 581-589
54. Shimizu S., Kiyosawa K., Sodeyama T., Tanaka E., and Nakano M. High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan. J Gastroenterol Hepatol 7 1 (1992) 30-35
55. Cooksley W. Chronic liver disease: do alcohol and hepatitis C virus interact. J Gastroenterol Hepatol 11 2 (1996) 187-192
56. Rothman K.J., and Greenland S. Modern epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia, PA 1
57. Corrao G., Torchio P., Zambon A., Ferrari P., Arico S., and di Orio F. Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Eur J Epidemiol 14 5 (1998) 447-456
58. Khan M.H., Thomas L., Byth K., et al. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?. J Gastroenterol Hepatol 13 4 (1998) 419-426
59. Serfaty L., Chazouilleres O., Poujol-Robert A., et al. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology 26 3 (1997) 776-779
60. Sachithanandan S., Kay E., Leader M., and Fielding J.F. The effect of light drinking on HCV liver disease: the jury is still out. Biomed Pharmacother 51 6-7 (1997) 295-297
61. Ostapowicz G., Watson K.J., Locarinini S.A., and Desmond P.V. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 27 6 (1998) 1730-1735
62. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
63. Katakami Y., Ohishi H., Komatsu H., and Kirizuka K. Alcohol intake increases hepatitis C virus-induced hepatocellular injury. Intern Med 34 12 (1995) 1153-1157
64. Smith B.C., Chapman C.E., Burt A.D., Toms G.L., and Bassendine M.F. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors. QJM 90 9 (1997) 587-592
65. Shen C.Y., Lee H.S., Huang L.C., Tsai K.S., Chen D.S., and Cheng A.T. Alcoholism, hepatitis B and C viral infections, and impaired liver function among Taiwanese aboriginal groups. Am J Epidemiol 143 9 (1996) 936-942
66. Alemy-Carreau M., Durbec J.P., Giordanella J., et al. Lack of interaction between hepatitis C virus and alcohol in the pathogenesis of cirrhosis. A statistical study. J Hepatol 25 5 (1996) 627-632
67. Wiley T.E., McCarthy M., Breidi L., and Layden T.J. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28 3 (1998) 805-809
68. Mathurin P., Moussalli J., Cadranel J.F., et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 27 3 (1998) 868-872
69. Frieden T.R., Ozick L., McCord C., et al. Chronic liver disease in central harlem: the role of alcohol and viral hepatitis. Hepatology 29 3 (1999) 883-888
70. Strasser S.I., Watson K.J., Lee C.S., Coghlan P.J., and Desmond P.V. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust 162 7 (1995) 355-358
71. Hourigan L.F., Macdonald G.A., Purdie D., et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29 4 (1999) 1215-1219
72. Pol S., Lamorthe B., Thi N.T., et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 28 6 (1998) 945-950
73. Shiomi S., Kuroki T., Minamitani S., et al. Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 7 3 (1992) 274-276
74. Healey C.J., Chapman R.W., and Fleming K.A. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transminases. Gut 37 2 (1995) 274-278
75. Shev S., Dhillon A.P., Lindh M., et al. The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. Liver 17 5 (1997) 215-223
76. Ohta S., Watanabe Y., and Nakajima T. Consumption of alcohol in the presence of hepatitis C virus is an additive risk for liver damage. Prev Med 27 3 (1998) 461-469
77. Kondili L.A., Tosti M.E., Szklo M., et al. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case-control study in Albania. Epidemiol Infect 121 2 (1998) 391-395
78. Verbaan H., Widell A., Bondeson L., Andersson K., and Eriksson S. Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence. J Viral Hepatitis 5 1 (1998) 43-51
79. Ikeda K., Saitoh S., Suzuki Y., et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28 6 (1998) 930-938
80. Seeff L.B., Buskell-Bales Z., Wright E.C., et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 327 27 (1992) 1906-1911
81. Uchimura Y., Sata M., Kage M., Abe H., and Tanikawa K. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 15 6 (1995) 300-306
82. Rosman A.S., Paronetto F., Galvin K., Williams R.J., and Lieber C.S. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis. Arch Intern Med 153 8 (1993) 965-969
83. Corrao G., Ferrari P.A., and Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol 142 11 (1995) 1136-1146
84. Marsano L.S., and Pena L.R. The interaction of alcoholic liver disease and hepatitis C. Hepatogastroenterology 45 20 (1998) 331-339
85. Poikolainen K. Alcohol and overall health outcomes. Ann Med 28 5 (1996) 381-384
86. [Erratum, J Clin Epidemiol 1995; 48(9):i]. Poikolainen K. Alcohol and mortality: a review. J Clin Epidemiol 48 4 (1995) 455-465
87. Rehm J., and Bondy S. Alcohol and all-cause mortality: an overview. Novartis Found Symp 216 (1998) 223-232
88. Makela P., Valkonen T., and Poikolainen K. Estimated numbers of deaths from coronary heart disease "caused" and "prevented" by alcohol: an example from Finland. J Stud Alcohol 58 5 (1997) 455-463
89. Rehm J.T., Bondy S.J., Sempos C.T., and Vuong C.V. Alcohol consumption and coronary heart disease morbidity and mortality. Am J Epidemiol 146 6 (1997) 495-501
90. Peters K.D., Kochanek K.D., and Murphy S.L. Deaths: final data for 1996 (1998), National Center for Health Statistics, Hyattsville, MD 19
91. Nalpas B., Pol S., Thepot V., Berthelot P., and Brechot C. Hepatocellular carcinoma in alcoholics. Alcohol 12 2 (1995) 117-120
92. 3 Suppl 1. Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Hepatology 26 (1997) 34S-38S
93. Ikeda K., Saitoh S., Koida I., et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18 1 (1993) 47-53
94. Donato F., Tagger A., Chiesa R., et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 26 3 (1997) 579-584
95. Chang C.C., Yu M.W., Lu C.F., Yang C.S., and Chen C.J. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Tai-wan. J Med Virol 43 3 (1994) 276-280
96. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in Western comtries. Hepatogastroenterology 45 Suppl 3 (1998) 1206-1213
97. Donato F., Boffetta P., and Puoti M. A meta-analysis of epidemiological studies on the combinedeffect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75 3 (1998) 347-354
98. Goritsas C.P., Athanasiadou A., Arvaniti A., and Lampropoulou-Karatza C. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study. J Clin Gastroenterol 20 3 (1995) 220-224
99. Pagliaro L., Simonetti R.G., Craxi A., Spano C., Ligippazzo M.G., and Palazzo V. Alcohol and HBV infection as risk factors for hepatocellular carcinoma in Italy: a multicentric, controlled study. Hepatogastroenterology 30 (1983) 48-50
100. (1 Suppl). Miyakawa H., Izumi N., Marumo F., and Sato C. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis. Alcohol: Clin Exp Res 20 (1996) 91A-94A
101. Simonetti R.G., Camma C., Fiorello F., et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 116 2 (1992) 97-102
102. Takase S., Tsutsumi M., Kawahara H., Takada N., and Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 17 1 (1993) 9-13
103. Chiba T., Matsuzaki Y., Abei M., et al. Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. J Gastroenterol 31 4 (1996) 552-558
104. Suzuki M., Suzuki H., Mizuno H., et al. Studies on the incidence of hepatocellular carcinoma in heavy drinkers with liver cirrhosis. Alcohol Alcohol, Suppl 1B (1993) 109-114
105. (1 Suppl). Noda K., Yoshihara H., Suzuki K., et al. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma-its relationship to alcohol drinking and the age of transfusion. Alcohol: Clin Exp Res 20 (1996) 95A-100A
106. Pawlosky R.J., Flynn B.M., and Salem N.J. The effects of low dietary levels of polyunsaturates on alcohol-induced liver disease in rhesus monkeys. Hepatology 26 6 (1997) 1386-1392
107. Pawlosky R.J., and Salem N.J. Alcohol consumption in rhesus monkeys depletes tissues of polyunsaturated fatty acids and alters essential fatty acid metabolism. Alcohol: Clin Exp Res 23 2 (1999) 311-317
108. Mezey E. Dietary fat and alcoholic liver disease. Hepatology 28 4 (1998) 901-905
109. (4 pt 1). Thurman II R.G. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275 (1998) G605-G611
110. Saad A.J., and Jerrells T.R. Flow cytometric and immunohistochemical evaluation of ethanol-induced changes in splenic and thymic lymphoid cell populations. Alcohol: Clin Exp Res 15 5 (1991) 796-803
111. Kruger T.E., and Jerrells T.R. Effects of ethanol consumption and withdrawal on B cell subpopulations in murine bone marrow. Clin Exp Immunol 96 3 (1994) 521-527
112. Geissler M., Gesien A., and Wands J.R. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. J Immunol 159 10 (1997) 5107-5113
113. (5 Suppl). Waltenbaugh C., Vasquez K., and Peterson J.D. Alcohol consumption alters antigen-specific Th1 responses: mechanisms of deficit and repair. Alcohol Clin Exp Res 22 (1998) 220S-223S
114. Peterson J.D., Herzenberg L.A., Vasquez K., and Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 95 (1998) 3071-3076 6
115. Colell A., Garcia-Ruiz C., Miranda M., et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115 6 (1998) 1541-1551
116. Calabrese V., Randazzo G., Ragusa N., and Rizza V. Long-term ethanol administration enhances age-dependent modulation of redox state in central and peripheral organs of rat: protection by metadoxine. Drugs Exp Clin Res 24 2 (1998) 85-91
117. Wang J.F., and Spitzer J.J. Alcohol-induced thymocyte apoptosis is accompanied by impaired mitochondrial function. Alcohol 14 1 (1997) 99-105
118. (5 Suppl). Szabo G. Monocytes, alcohol use, and altered immunity. Alcohol: Clin Exp Res 22 (1998) 216S-219S
119. Szabo G., Chavan S., Mandrekar P., and Catalano D. Acute alcohol consumption attenuates interleukin-8 (IL-8) and monocyte chemoattractant peptide-1 (MCP-1) induction in response to ex vivo stimulation. J Clin Immunol 19 1 (1999) 67-76
120. In: Bissell D.M., Maher J.J., Zakim D., and Boyer T.D. (Eds). Hepatology: a textbook of liver disease. 3rd ed. (1996), Saunders, Philadelphia, PA 506-525
121. Okada S., Ishii H., Nose H., et al. Effect of heavy alcohol intake on long-term results after curative resection of hepatitis C virus-related hepatocellular carcinoma. Jpn J Cancer Res 87 8 (1996) 867-873
122. Okazaki T., Yoshihara H., Suzuki K., et al. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Scand J Gastroenterol 29 11 (1994) 1039-1043
123. Ohnishi K., Matsuo S., Matsutani K., et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 91 7 (1996) 1374-1379
124. Olynyk J.K., Reddy K.R., Di Bisceglie A.M., et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatits C. Gastroenterology 108 4 (1995) 1104-1109
125. Izumi N., Enomoto N., Uchihara M., et al. Hepatic iron contents and response to interferonalpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus. Dig Dis Sci 41 5 (1996) 989-994
126. Ono K., Sata M., Murashima S., Fukuizumi K., Suzuki H., and Tanikawa K. Biological responses to administered interferon in alcoholics. Alcohol Clin Exp Res 20 9 (1996) 1560-1563
127. Belle S.H., Beringer K.C., and Detre K.M. Liver transplantation for alcoholic liver disease in the United States: 1988 to 1995. Liver Transplant Surg 3 3 (1997) 212-219
128. Everhart J.E., and Beresford T.P. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transplant Surg 3 3 (1997) 220-226
129. Everson G., Bharadhwaj G., House R., et al. Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transplant Surg 3 3 (1997) 263-274
130. Lee R.G. Recurrence of alcoholic liver disease after liver transplantation. Liver Transplant Surg 3 3 (1997) 292-295
131. Leach M., Makris M., Gleeson D.C., and Preston F.E. Acute liver failure induced by alcohol and paracetamol in an HCV-infected haemophiliac. Br J Haematol 103 3 (1998) 891-893